Exploring Factors Associated with Prescribers' Comfort Levels in Analgesic Prescribing in Quebec

• Published in: Journal of pain research Vol. 17; pp. 2667 - 2677
• Main Authors: Naeem, Usra, De Clifford-Faugère, Gwenaelle, Godbout-Parent, Marimée, Nguena Nguefack, Hermine Lore, Lacasse, Anaïs
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 31.08.2024; Dove; Dove Medical Press
• Subjects: Care and treatment; Chronic pain; Evidence-based medicine; factors; healthcare professionals; Medical care; Medical personnel; medications; nurse; Nurse practitioners; Opioids; Original Research; Pain; pharmacist; pharmacological treatment; Pharmacy; physician; Prescription writing; Quality management; Training; Canada; Quebec; pharmacological treatment; medications; sex; nurse; pharmacist; physician; healthcare professionals; factors
• ISSN: 1178-7090; 1178-7090
• DOI: 10.2147/JPR.S469052

Identifying the factors associated with comfort level when prescribing medications is important for tailoring education and training. This study aimed to explore factors associated with the comfort level of healthcare professionals regarding dispensing and adjusting prescriptions for the treatment of chronic pain (CP). A cross-sectional survey was conducted among licensed physicians, pharmacists, and nurse practitioners across the province of Quebec, Canada. Comfort level regarding dispensing and/or adjusting prescriptions for CP treatment was measured on a 0-10 rating scale (0 = very uncomfortable, 10 = very comfortable). In total, 207 prescribers participated in this study (83 physicians, 58 pharmacists, and 66 nurse practitioners). 56.5% reported a comfort level in dispensing and/or adjusting prescriptions for the treatment of CP <6/10. The median comfort level score was 6 (interquartile range - IQR: 2). Differences in median scores were found between physicians (6), pharmacists (7) and nurses (5; p < 0.001). Multivariable logistic regression revealed that the factors associated with an increased likelihood of reporting a high comfort level (≥6/10) were: being a pharmacist, having a relative living with CP, a greater percentage of past year continuing educational activities about CP management, and higher perception of short-acting opioids risks. Factors associated with lower comfort levels were as follows: being a nurse practitioner, having fewer years of experience, living in a remote region, living with CP, and a higher perception of long-acting opioids risks. The practice setting and sex at birth were also associated with comfort level. The comfort level regarding prescribing for CP varies according to socioeconomic/professional factors, which can lead to disparities in the quality of care and outcomes for patients. Our results reinforce the importance of investing in initial training and continuing education of prescribers.